Nadezhda Malkova - Novosibirsk State Regional Clinical Hospital, Novosibirsk State Medical University

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Multiple sclerosis: modern diagnostic markers and prognostic factors of disease progression

A. I. Prokaeva, I. E. Arkhipov, E. E. Dorchinets, D. S. Korobko,N. A. Malkova

Сибирский научный медицинский журналno. 1 (2024): 39-51

引用0浏览0引用

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

A.N. Boyko, V.M. Alifirova, I.G. Lukashevich, Z.A. Goncharova, I.V. Greshnova, L.G. Zaslavsky,S.V. Kotov,N.A. Malkova, G.N. Mishin, E.V. Parshina, I.Ye. Poverennova, L.N. Prakhova,

S.S. Korsakov Journal of Neurology and Psychiatry（2024）

引用0浏览0引用

[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]

A N Boyko, V M Alifirova, I G Lukashevich, Z A Goncharova, I V Greshnova, L G Zaslavsky,S V Kotov,N A Malkova, G N Mishin, E V Parshina, I Ye Poverennova, L N Prakhova,

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova（2024）

引用0浏览0WOS引用

COVID-19 and multiple sclerosis: is there a connection

I. E. Arkhipov, A. I. Prokaeva, A. V. Zateev, V. K. Kozyreva, D. S. Korobko,N. A. Malkova

Сибирский научный медицинский журналno. 1 (2024): 7-14

引用0浏览0引用

POEMS-syndrome

Ivan Ie. Arkhipov, I. Yu. Vergunova,N A Malkova, D. S. Korobko

Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakovano. 7 (2023): 15-15

引用0浏览0引用

[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2]

A N Boyko,V M Alifirova, I G Lukashevich,Z A Goncharova, I V Greshnova, L G Zaslavsky,S V Kotov,N A Malkova, G N Mishin, E V Parshina, I Ye Poverennova, L N Prakhova,

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakovano. 4 (2023): 37-47

引用1浏览0WOS引用

[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS]

A N Boyko,V M Alifirova, I G Lukashevich, Z A Goncharova, I V Greshnova, L G Zaslavsky,S V Kotov,N A Malkova, G N Mishin, E V Parshina, I Ye Poverennova, L N Prakhova,

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova（2023）

引用0浏览0WOS引用

[POEMS-syndrome]

I E Arkhipov,I Yu Vergunova,N A Malkova, D S Korobko

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova（2023）

引用0浏览0WOS引用

Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia

A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman,Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova,

Neurology, Neuropsychiatry, Psychosomaticsno. 1S (2022): 9-15

引用0浏览0引用

Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders

A. N. Boyko, K. Z. Bakhtiyarova, L. V. Brylev, M. N. Zakharova,D. S. Kasatkin, D. S. Korobko,S. V. Kotov,V. S. Krasnov,N. A. Malkova, E. V. Popova, S. A. Sivertseva, T. O. Simaniv,

Neurology, Neuropsychiatry, Psychosomatics（2021）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn